Dr. Clinton Thomas Gott, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 14 Hummingbird Cir, Henderson, NV 89014 Phone: 702-450-3322 Fax: 702-891-0970 |
Michael Joseph Olek, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 874 American Pacific Dr, Henderson, NV 89014 Phone: 702-777-4809 Fax: 702-777-4822 |
Dr. Richard Floyd Cook, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1109 Thunder Canyon Ave, Henderson, NV 89012 Phone: 801-471-3716 |
Dr. Derek A Duke, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 861 Coronado Center Dr, Suite 200, Henderson, NV 89052 Phone: 702-896-0940 Fax: 702-896-6173 |
Dr. James S Forage, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 861 Coronado Center Dr, Suite 200, Henderson, NV 89052 Phone: 702-896-0940 Fax: 702-896-6173 |
Paul C Williams, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2505 Anthem Village Dr., Suite E-606, Henderson, NV 89052 Phone: 503-704-7045 Fax: 503-691-0381 |
Randal Raymond Peoples, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2865 Siena Heights Dr Ste 131, Henderson, NV 89052 Phone: 702-616-6580 |
News Archive
Prenatal exposure to some flame retardants that have been widely-used in consumer products is associated with attention problems in children ages three through seven, according to a new study by researchers at the Columbia Center for Children's Environmental Health, within Columbia's Mailman School of Public Health.
The new portable device is able to detect both the electrical activity emitted by the heart of the mom as from the unborn baby's.
Over 2,300 running enthusiasts and members of the community came together to participate in the third annual Thanksgiving Day 5K. Thousands of crew, volunteers and spectators supported the racers along the 3.1 mile route.
Idera Pharmaceuticals today provides an update on the clinical development of IMO-2055 (EMD 1201081), a TLR9 agonist for cancer treatment being developed by Merck KGaA, Darmstadt, Germany, under its collaboration with Idera.
"Antibiotics can't hurt. They might even make me feel better. Why not take a risk?" You may have had similar thoughts when sick with the flu or common cold. Your doctor may think so too.
› Verified 5 days ago